Spring Creek Capital’s Usana Health Sciences USNA Stock Holding History

Spring Creek Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,545	Closed	-$409K	–	654
2018 Q2	$409K	Buy	+3,545	New	+$388K	0.05%	496

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Spring Creek Capital's USNA Position: Q3 2018 in Review

Spring Creek Capital sold out of Usana Health Sciences (USNA) in Q3 2018, closing a stake of 3,545 shares — an estimated $409K sold.

Spring Creek Capital first reported a position in USNA in Q2 2018 and held it in 1 quarter. The position peaked at $409K in Q2 2018. 197 funds tracked by Wall St. Rank hold USNA as of Q3 2018.

Spring Creek Capital reported no remaining Usana Health Sciences position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 3,545 Usana Health Sciences shares in Q3 2018, an estimated $409K.
Spring Creek Capital first reported a position in Usana Health Sciences in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's Usana Health Sciences position peaked at $409K in Q2 2018.
197 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.